Todd Hultman
Nurse Practitioner · Santa Fe, NMNPI 1184669806
Payments from drug & device makers
Across 36 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$88
- Johnson & Johnson$71
- Daiichi Sankyo Inc.$67
- Bayer$62
- AstraZeneca$55
- Jazz Pharmaceuticals Inc.$50
- plus $350 from 17 others
What the payments were for
- Food & beverage$742100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 4 | $88 |
| Johnson & Johnson | 3 | $71 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Bayer | 3 | $62 |
| AstraZeneca | 3 | $55 |
| Jazz Pharmaceuticals Inc. | 2 | $50 |
| Springworks Therapeutics, Inc. | 2 | $37 |
| Sanofi | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Genmab U.S., Inc. | 1 | $23 |
| Exelixis Inc. | 1 | $23 |
| Geron Corporation | 1 | $21 |
| Tersera Therapeutics LLC | 1 | $21 |
| Novocure Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $18 |
| Incyte Corporation | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
| GSK | 1 | $13 |
How this compares
$742 in reported general payments places this provider in the 80th percentile of 624 nurse practitioner providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $5,956 |
| Fentanyl | 11 | $983 |
| Mirtazapine | 14 | $634 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $419 |
| Oxycodone Hcl | 24 | $406 |
| Gabapentin | 57 | $346 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $296 |
| Pregabalin | 16 | $225 |
| Trazodone Hcl | 14 | $127 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Santa Fe
- Ryan CommiskeySanta Fe$18K
- Laura DevorSanta Fe$6K
- Jennifer PenningSanta Fe$5K
- Jennifer PorterSanta Fe$3K
- Lissa ShafferSanta Fe$2K
- Eliezer PanganSanta Fe$2K
- Marisa EscobarAlbuquerque$36K
- Catherine SollerAlbuquerque$33K
- Lauren HeckethornRio Rancho$14K
- Christina ParksAlbuquerque$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.